Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) recently highlighted encouraging new clinical data for its allogeneic CAR-T therapy ...

Sam Neill announces he is cancer-free after taking part in Australian clinical trial: ‘I’m very, very excited’

Jurassic Park actor is advocating for CAR T-cell therapy, which he underwent as part of a clinical trial, to be rolled out for blood cancer patients across Australia ...
New Scientist

CAR T-cell therapy bolstered by stiffening up cancer cells first

CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand ...

CAR T moves beyond cancer, targeting autoimmune disease with immune system reset

At age 49, Jan Janisch-Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her ...

Study identifies key protein in immune cell exhaustion in cancer immunotherapy

CAR T-cell therapy is considered a milestone in personalized cancer treatment. In this approach, a patient's own immune cells ...

Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers

Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful ...

New CAR-T cell method may allow some cancer patients to skip chemotherapy

We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease ...
Medscape

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

A blood test following CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL) appears to do a better job than PET-CT scans at predicting which patients have poor prognoses, a small, ...